Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+46.0%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
+46.0%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
6.6x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 86.15% |
| 2024 | 68.50% |
| 2023 | 27.37% |
| 2022 | -17.95% |
| 2021 | -33.39% |
| 2020 | 12.99% |
| 2019 | 7.17% |
| 2018 | 4.88% |
| 2017 | 17.28% |
| 2016 | 32.07% |